头颈部放疗诱发肉瘤:临床特征与分子特征
该研究回顾性评估1994至2019年间24例因头颈部癌接受放疗后发生肉瘤的患者,按RISHN潜伏期分组分析临床病理特征与生存,并对部分样本行全外显子测序。结果显示中位诊断年龄54岁,男女比2:1,潜伏期0.8至64.4年(中位6.5年),中位生存21.5个月;口腔原发癌、烷化剂治疗、饮酒、嚼槟榔和吸烟为短潜伏期(<5年)的危险因素;多数RISHN发生于口腔(58.3%);WES显示肿瘤坏死因子和细胞周期检查点通路在两组中差异参与。
要点
- RISHN潜伏期中位6.5年,范围0.8至64.4年,中位生存21.5个月。
- 口腔原发癌、烷化剂治疗、饮酒、嚼槟榔和吸烟与短于5年的潜伏期相关。
- 58.3%的RISHN发生于口腔,WES示TNF与细胞周期检查点通路差异参与。
核心结论
- 尽管病例数少,该队列是迄今来自单中心的最大RISHN病例系列;临床医生须了解影响RISHN发生与潜伏期的因素,识别危险因素可能有助于未来更早发现和预防。
研究设计与样本
- 回顾性评估1994至2019年间因头颈部癌接受放疗的24例肉瘤患者,按RISHN潜伏期分为两组,分析人口学、初诊肿瘤分期、危险因素和生存,并对选定样本行全外显子测序(WES)。
主要发现
- RISHN诊断时中位年龄54岁,男女比为2:1。
- 潜伏期为0.8至64.4年(中位6.5年),中位生存21.5个月。
- 口腔原发癌、烷化剂治疗、饮酒、嚼槟榔和吸烟被确定为短于5年潜伏期的危险因素。
- 多数RISHN病例发生于口腔(58.3%)。
- WES分析显示肿瘤坏死因子和细胞周期检查点通路在两组患者中差异参与。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文自述病例数少(case numbers were small)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation-induced sarcoma of the head and neck (RISHN) is a rare yet devastating potential complication of radiotherapy treatment. We aimed to evaluate the clinicopathological characteristics and molecular signatures of RISHN in patients who underwent radiotherapy for head and neck cancer (HNC) to identify high-risk patients and enable earlier cancer detection. METHODS: This study retrospectively evaluated 24 sarcoma patients who received radiotherapy for HNC between 1994 and 2019. Patients were divided into two groups based on RISHN latency period. Patient demographics, initial tumor staging, risk factors, and survival between groups were analyzed, and whole-exome sequencing (WES) of selected samples was performed. RESULTS: The median age at diagnosis of RISHN was 54 years, and the male-to-female ratio was 2:1. The latency period ranged from 0.8 to 64.4 years (median 6.5 years), with a median survival of 21.5 months. Primary cancer in the oral cavity, treatment with alkylating agents, alcohol consumption, betel nut chewing, and smoking were identified as risk factors for short (<5 years) latency periods. The majority of RISHN cases occurred in the oral cavity (58.3%). WES analysis showed that tumor necrosis factor and cell cycle checkpoint pathways were differentially involved in both patient groups. CONCLUSIONS: Although case numbers were small, our cohort represents the largest case series of RISHN from a single institution to date. Clinicians must be aware of factors affecting RISHN development and latency, and risk factor identification may lead to earlier detection and prevention in the future.
引用
- Liao YH, Hsu CL, Leu CY, et al. Radiation-induced sarcoma of head and neck: Clinical characteristics and molecular signatures. Head Neck. 2022. PMID: 36513597. doi:10.1002/hed.27279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。